384
Participants
Start Date
May 1, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Artemether-lumefantrine and Amodiaquine Drug Combination
AL and AQ will be given together for three days then followed by placebo for three days
Artemether-lumefantrine then Artesunate amodiaquine
AL will be given twice a day for three days then followed by artesunate amodiaquine once a day for three days
Artemether-lumefantrine
This will be the comparator arm as standard treatment, where only AL will be given twice a day for three days then placebo for three days
RECRUITING
Kibindu, Bagamoyo
SUSPENDED
Yombo Dispensary, Bagamoyo
The Swedish Research Council
OTHER_GOV
Uppsala University
OTHER
Muhimbili University of Health and Allied Sciences
OTHER